Short-Term Lipid Changes Associated With Highly Active Antiretroviral Therapy in Naive HIV-Infected Patients
- 1 October 2003
- journal article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 34 (2) , 249-251
- https://doi.org/10.1097/00126334-200310010-00021
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort studyPublished by Elsevier ,2001
- Lipodystrophy-associated morphological, cholesterol and triglyceride abnormalities in a population-based HIV/AIDS treatment databaseAIDS, 2001
- Lipodystrophy, Metabolic Disorders, and Human Immunodeficiency Virus Infection: Aquitaine Cohort, France, 1999Clinical Infectious Diseases, 2000
- Effects of Protease Inhibitors on Hyperglycemia, Hyperlipidemia, and LipodystrophyArchives of internal medicine (1960), 2000
- Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infectionAIDS, 2000
- A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndromeAIDS, 2000
- Fat distribution evaluated by computed tomography and metabolic abnormalities in patients undergoing antiretroviral therapy: preliminary results of the LIPOCO* studyAIDS, 2000
- Fat distribution and metabolic changes in patients with HIV infectionAIDS, 1999
- Lipodystrophy in patients naive to HIV protease inhibitorsAIDS, 1999
- A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitorsAIDS, 1998